Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Antibiotics (Basel) ; 9(1)2019 Dec 30.
Article in English | MEDLINE | ID: mdl-31906000

ABSTRACT

AIM: To verify a possible association between overall H. pylori and CagA+ H. pylori infection and autoimmune thyroid diseases (AITDs). METHODS: Consecutive patients with AITDs admitted to one single centre of Endocrinology during one solar year were examined. The diagnoses were Hashimoto thyroiditis (HT) in 76, Graves' Disease (GD) in 39, and aspecific thyroiditis (AT) in 44 patients. Controls were 136 individuals without AITDs. Median values of fT3, fT4, anti-thyreoglobulin (Tg) antibodies, IL-1ß, IL-6, and TNF-α in patients were compared with those in controls. H. pylori infection and CagA status were determined serologically. Structural homology of some thyroid proteins with H. pylori antigens was investigated. RESULTS: H. pylori infection prevalence was significantly increased in GD (66.6%) and HT (64.4%) patients, vs. 29.4% of controls and 34.0% of AT. CagA seropositivity was significantly more frequent in GD (46.1%) and HT (46.9%) infected patients, vs. infected controls (20%). fT3 and fT4 median values were significantly decreased in infected CagA+ GD patients vs. uninfected GD patients. IL-1ß median values were increased in patients respect to controls, independently of the clinical form of AITD. Median values of IL-6, TNF-α and anti-Tg autoantibodies in CagA infected patients were significantly higher than those measured in infected CagA- and uninfected patients and in infected CagA+ controls. The examined thyroid proteins shared putative conserved domains with numerous bacterial antigens. CONCLUSIONS: Overall H. pylori and CagA+ H. pylori infection were associated with GD and HT, putatively through an increased inflammatory status and molecular mimicry.

2.
J Clin Endocrinol Metab ; 103(6): 2362-2368, 2018 06 01.
Article in English | MEDLINE | ID: mdl-29672763

ABSTRACT

Context: Recently, the American Thyroid Association (ATA) and the European Thyroid Association (ETA) have proposed that thyroid ultrasound (US) should be used to stratify the risk of malignancy in thyroid nodules and to aid decision-making about whether fine-needle aspiration cytology (FNAC) is indicated. Objective: To validate and to compare the ATA and ETA US risk stratification systems of thyroid nodules in a prospective series of thyroid nodules submitted to FNAC. Setting: We prospectively evaluated 432 thyroid nodules selected for FNAC from 340 patients. Cytology reports were based on the five categories according to the criteria of the British Thyroid Association. Results: The proportion of Thy2 nodules decreased significantly, whereas the proportion of Thy4/Thy5 nodules significantly increased with increasing US risk class (P < 0.0001). The ability to identify benign and malignant nodules was similar between ATA and ETA systems. According to ATA and ETA US risk stratification systems, 23.7% and 56.0% nodules did not meet the criteria for FNAC, respectively. Considering only categories at lower risk of malignancy, the cumulative malignancy rate in these nodules was 1.2% for ATA and 1.7% for ETA US risk stratification systems. Conclusions: ETA and ATA US risk stratification systems provide effective malignancy risk stratification for thyroid nodules. In clinical practice, using this approach, we should be able to reduce the number of unnecessary FNAC without losing clinically relevant thyroid cancer.


Subject(s)
Biopsy, Fine-Needle , Thyroid Gland/diagnostic imaging , Thyroid Nodule/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Cytodiagnosis , Female , Humans , Male , Middle Aged , Prospective Studies , Risk Factors , Thyroid Gland/pathology , Thyroid Nodule/pathology , Young Adult
3.
J Androl ; 28(1): 194-9, 2007.
Article in English | MEDLINE | ID: mdl-16988323

ABSTRACT

Cryptorchidism is a pathological condition defined as the failure of the testis to descend into the scrotum, the location of the cryptorchid testis can be in the inguinal canal or in the prescrotal and abdominal area, sometimes resulting in atrophic seminiferous tubules. The aim of this study was to analyze semen quality of men who underwent orchidopexy for unilateral or bilateral cryptorchidism during childhood. Semen quality was investigated by light microscopy to evaluate sperm concentration and motility. Sperm morphology was performed by transmission electron microscope (TEM), and the data were mathematically elaborated. The presence of Y microdeletions was investigated by polymerase chain reaction. The effect of cryptorchidism on meiosis was explored by fluorescence in situ hybridization (FISH). The incidence of azoospermia was higher in the group with bilateral compared with unilateral cryptorchidism, and semen parameters were better in the unilateral group. Sperm pathologies detected by TEM indicated a severe deterioration of sperm quality in both groups. Necrosis and apoptosis appeared to be the most frequent pathologies, and their values reached statistical significance compared with those from fertile controls. The presence of chromosome Y microdeletions in patients with cryptorchidism and severe spermatogenetic defects is controversial. No microdeletions were found in this study. FISH values indicated that the mean percentage of gonosome disomies and diploidies were generally out of normal range, indicating a severe disturbance of meiotic segregation. The effects induced by cryptorchidism resolved in childhood seem to include a spermatogenetic impairment, leading to recommendation of detailed ultrastructural and chromosomal sperm analyses before undertaking assisted reproductive techniques.


Subject(s)
Cryptorchidism/physiopathology , Semen , Adult , Child , Child, Preschool , Chromosome Deletion , Chromosomes, Human, Y , Cryptorchidism/genetics , Cryptorchidism/surgery , Cryptorchidism/ultrastructure , Humans , In Situ Hybridization, Fluorescence , Infant , Male , Polymerase Chain Reaction , Semen/diagnostic imaging , Sperm Count , Sperm Motility , Ultrasonography
4.
Thyroid ; 15(9): 1041-5, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16187912

ABSTRACT

We investigated whether serum thyroglobulin determination before surgery for differentiated thyroid carcinoma may have any prognostic value with regard to tumour extension and disease outcome in a retrospective series of 71 patients with papillary thyroid cancer. Presurgical serum thyroglobulin levels were correlated with the size of the primary tumoral nodule (p = 0.006) and of the whole thyroid (p = 0.02). The same correlation was found in a control group of patients with benign thyroid nodules, confirming that presurgical serum thyroglobulin cannot be used for the differential diagnosis of thyroid carcinoma. Presurgical serum thyroglobulin levels did not differ among patients with tumor limited to thyroid gland or extending to cervical lymph nodes or invading outside the thyroid capsule or metastasising to distant size. In addition presurgical serum thyroglobulin levels were not correlated with the disease outcome after a mean follow-up of 9 years: no difference was found among patients in complete remission or with persistent disease or dead from thyroid cancer. In conclusion, this study failed to show any prognostic value of presurgical serum thyroglobulin determination that consequently should not be measured.


Subject(s)
Carcinoma, Papillary/blood , Carcinoma, Papillary/diagnosis , Thyroglobulin/blood , Thyroid Neoplasms/blood , Thyroid Neoplasms/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Autoantibodies/analysis , Carcinoma, Papillary/pathology , Child , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Thyroid Neoplasms/pathology , Thyrotropin/blood , Treatment Outcome
5.
Eur J Nucl Med Mol Imaging ; 31(10): 1443-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15365778

ABSTRACT

Management of thyroid nodules is one of the most controversial issues in thyroidology. Different approaches derive from geographical variation in presentation, inadequate or incomplete clinical diagnosis, lack of prospective controlled studies and, frequently, the different cultural backgrounds of physicians. This review aims to offer a practical approach to the management of nodular thyroid disorders, considering the way in which the pathophysiology of the disease provides clues to the correct clinical diagnosis and therapy.


Subject(s)
Practice Guidelines as Topic , Practice Patterns, Physicians' , Thyroid Nodule/diagnosis , Thyroid Nodule/therapy , Animals , Clinical Trials as Topic , Diagnosis, Differential , Evidence-Based Medicine , Humans , Thyroid Nodule/classification
SELECTION OF CITATIONS
SEARCH DETAIL